financetom
Business
financetom
/
Business
/
Market Chatter: Miniso Selects JPMorgan, UBS for Top Toy's Hong Kong IPO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Miniso Selects JPMorgan, UBS for Top Toy's Hong Kong IPO
Jun 4, 2025 3:11 AM

05:54 AM EDT, 06/04/2025 (MT Newswires) -- Miniso ( MNSO ) has selected JPMorgan Chase ( JPM ) and UBS (UBS) to lead the planned Hong Kong initial public offering of its toy unit, Top Toy, Bloomberg reported Wednesday, citing unnamed sources familiar with the matter.

The report said the company is also seeking new investors for Top Toy, including potential backing from sovereign wealth funds, ahead of the offering.

Additional banks may be brought on board for the IPO, the sources said.

Miniso ( MNSO ), JPMorgan ( JPM ) and UBS did not immediately respond to MT Newswires' requests for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
MedImpact Expands Portfolio of Health Solutions with Acquisition of Two Employer Insurance and Risk Management Companies
MedImpact Expands Portfolio of Health Solutions with Acquisition of Two Employer Insurance and Risk Management Companies
Mar 12, 2026
SRS Benefit Partners and MSL Captive Solutions provide alternative risk financing solutions that protect employers from sky-high administrative fees and renewals SAN DIEGO--(BUSINESS WIRE)-- MedImpact Holdings, Inc., the nation’s largest independent health solutions and pharmacy benefit company, today announced the acquisition of two innovative risk management firms: MHW Benefit Partners (formerly SRS Benefit Partners) and MSL Captive Solutions. These...
Motorola Solutions Acquires Exacom, a Leading Provider of Cloud-Native Recording and Logging Solutions for Mission-Critical 911 and Radio Communications
Motorola Solutions Acquires Exacom, a Leading Provider of Cloud-Native Recording and Logging Solutions for Mission-Critical 911 and Radio Communications
Mar 12, 2026
CHICAGO--(BUSINESS WIRE)-- Motorola Solutions ( MSI ) today announced it has acquired Exacom, a leading provider of cloud-native voice and multimedia recording and logging solutions for mission-critical communications, based in Manchester, New Hampshire. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260311755689/en/ Exacom’s solutions help public safety agencies consolidate call logs and record 911 audio and radio traffic...
Alchelyst and Lyra Client Solutions Complete Combination, Creating a Purpose-Built Platform to Support the Evolving Needs of Private Markets
Alchelyst and Lyra Client Solutions Complete Combination, Creating a Purpose-Built Platform to Support the Evolving Needs of Private Markets
Mar 12, 2026
Newly combined company will focus on delivering technology-enabled client service and next-generation infrastructure to support the growth of private markets firms NEW YORK & DUBLIN--(BUSINESS WIRE)-- Alchelyst and Lyra Client Solutions today announced the completion of their merger. The combined company, backed by Motive Partners and anchor client Apollo , is focused on supporting the continued evolution of private...
Enodia Therapeutics Strengthens Sec61 Portfolio Through Acquisition of Preclinical Assets from Kezar Life Sciences
Enodia Therapeutics Strengthens Sec61 Portfolio Through Acquisition of Preclinical Assets from Kezar Life Sciences
Mar 12, 2026
Transaction deepens insights into Sec61 selectivity for targeted protein degradation, supporting accelerated development of Enodia’s novel small-molecule inhibitors PARIS & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Enodia Therapeutics, a biotechnology company developing novel small-molecule therapies for targeted protein degradation at the point of synthesis, and Kezar Life Sciences, Inc. ( KZR ) , a clinical-stage biotechnology company developing novel small...
Copyright 2023-2026 - www.financetom.com All Rights Reserved